Commissioned by the Foundation for the Development of Science and Technology in China and the Hainan International Union Foundation for Healthcare Innovation, the China Association for Medical Devices Industry (CAMDI) and the China Strategic Alliance of Medical Device Innovation organized the "Medical Device Industry Technology Finance Service Matchmaking Meeting" online on July 1, 2025, which aimed to meet the full-cycle financing needs of medical device enterprises during their growth through modern technology finance means, provide exclusive financial products and comprehensive financial services, and support quality medical device enterprises in obtaining loans and financing.
Representatives from over 50 medical device enterprises participated online or offline to engage in enthusiastic discussions.
Jiang Feng, Executive Vice President of CAMDI and President of the China Strategic Alliance of Medical Device Innovation (Alliance), stated in his speech that CAMDI and the Alliance have been committed to promoting the innovative development of the medical device industry and have launched over 30 innovation services covering financing, ODM, and registration through organizing regular programs such as the China Medical Devices Design and Entrepreneurship Competition. However, while addressing technology and talent issues, device enterprises still face severe capital shortages. Innovative projects face challenges in animal and clinical trials, clinical promotion, and payment and billing for high-value devices. Furthermore, insufficient payment options outside medical insurance often constrain many medical devices from benefiting the public due to payment reasons. All this urgently requires technology-finance assistance for enterprises. Jiang expressed the hope to create and promote better financial services through this meeting and help innovative projects, innovative technologies, and relatively mature enterprises obtain higher-quality financing services in terms of enterprise products and financial operations.
Li Yang, full-time Deputy Secretary-General of the Foundation for the Development of Science and Technology in China and Director of the Life and Health Support Office, introduced that the Foundation for the Development of Science and Technology in China (Foundation) was established in 1988 under the supervision of the China Association for Science and Technology, as a national public offering foundation and that the Life and Health Support Office has conducted extensive work in developing systems for evaluating innovative oncology technologies, writing China's blue books on medical oncology products, establishing joint funds for science and technology development, and setting up the Beijing-Tianjin-Hebei Science and Technology Parlor. Currently, with peak financing values shrinking in Chinese and global biomedical sectors, medical device R&D and manufacturing enterprises are experiencing increasingly tight cash flows and mounting pressure on innovative R&D, production investments, and sales collection. Therefore, the Foundation has partnered with CAMDI to launch the project of technology finance supporting the medical device industry and will actively explore and communicate with government departments and major banks to implement more practical and effective technology finance innovations, thereby helping the medical device industry solve financing difficulties and promoting the industry's continuous high-quality development.
Subsequently, Wang Xiangda, Senior Partner of Shenzhen Deyuan Commercial Factoring Co., Ltd., delivered a keynote speech titled Medical Finance Innovation: Empowering the Pharmaceutical Industry with Technology Finance, explaining how to use modern technology finance means to provide personalized and customized financial support for enterprises' major innovation projects in animal experiments, clinical trials, large-quantity key component and raw material procurement, high-volume orders, specific market expansion activities, special high-priced product factoring advance sales, and hospital stagnant accounts receivable and how technology finance can empower enterprises' sci-tech innovation and industrial development. These innovative financial means can effectively alleviate capital pressure for medical device enterprises in R&D, production, and sales stages and help the industry achieve robust development in complex economic and medical environments.
During the discussion session, participating enterprises had in-depth discussions on practical issues such as enterprises' innovative R&D, early-stage development, early market entry of innovative products, overseas business accounts receivable, and how domestic and foreign-invested enterprises can access financial support, leading to an exceptionally lively atmosphere.
After the meeting, in response to the varied needs of participating enterprises, CAMDI and the Alliance have set up multiple special working groups to provide tailored services for the enterprises.
Furthermore, to meet the diverse financing needs of medical device enterprises, CAMDI and the Alliance will host additional technology finance service matchmaking meetings and online live streaming events in the near future. Please stay tuned.
Source: Innomd.org
Representatives from over 50 medical device enterprises participated online or offline to engage in enthusiastic discussions.
Jiang Feng, Executive Vice President of CAMDI and President of the China Strategic Alliance of Medical Device Innovation (Alliance), stated in his speech that CAMDI and the Alliance have been committed to promoting the innovative development of the medical device industry and have launched over 30 innovation services covering financing, ODM, and registration through organizing regular programs such as the China Medical Devices Design and Entrepreneurship Competition. However, while addressing technology and talent issues, device enterprises still face severe capital shortages. Innovative projects face challenges in animal and clinical trials, clinical promotion, and payment and billing for high-value devices. Furthermore, insufficient payment options outside medical insurance often constrain many medical devices from benefiting the public due to payment reasons. All this urgently requires technology-finance assistance for enterprises. Jiang expressed the hope to create and promote better financial services through this meeting and help innovative projects, innovative technologies, and relatively mature enterprises obtain higher-quality financing services in terms of enterprise products and financial operations.
Li Yang, full-time Deputy Secretary-General of the Foundation for the Development of Science and Technology in China and Director of the Life and Health Support Office, introduced that the Foundation for the Development of Science and Technology in China (Foundation) was established in 1988 under the supervision of the China Association for Science and Technology, as a national public offering foundation and that the Life and Health Support Office has conducted extensive work in developing systems for evaluating innovative oncology technologies, writing China's blue books on medical oncology products, establishing joint funds for science and technology development, and setting up the Beijing-Tianjin-Hebei Science and Technology Parlor. Currently, with peak financing values shrinking in Chinese and global biomedical sectors, medical device R&D and manufacturing enterprises are experiencing increasingly tight cash flows and mounting pressure on innovative R&D, production investments, and sales collection. Therefore, the Foundation has partnered with CAMDI to launch the project of technology finance supporting the medical device industry and will actively explore and communicate with government departments and major banks to implement more practical and effective technology finance innovations, thereby helping the medical device industry solve financing difficulties and promoting the industry's continuous high-quality development.
Subsequently, Wang Xiangda, Senior Partner of Shenzhen Deyuan Commercial Factoring Co., Ltd., delivered a keynote speech titled Medical Finance Innovation: Empowering the Pharmaceutical Industry with Technology Finance, explaining how to use modern technology finance means to provide personalized and customized financial support for enterprises' major innovation projects in animal experiments, clinical trials, large-quantity key component and raw material procurement, high-volume orders, specific market expansion activities, special high-priced product factoring advance sales, and hospital stagnant accounts receivable and how technology finance can empower enterprises' sci-tech innovation and industrial development. These innovative financial means can effectively alleviate capital pressure for medical device enterprises in R&D, production, and sales stages and help the industry achieve robust development in complex economic and medical environments.
During the discussion session, participating enterprises had in-depth discussions on practical issues such as enterprises' innovative R&D, early-stage development, early market entry of innovative products, overseas business accounts receivable, and how domestic and foreign-invested enterprises can access financial support, leading to an exceptionally lively atmosphere.
After the meeting, in response to the varied needs of participating enterprises, CAMDI and the Alliance have set up multiple special working groups to provide tailored services for the enterprises.
Furthermore, to meet the diverse financing needs of medical device enterprises, CAMDI and the Alliance will host additional technology finance service matchmaking meetings and online live streaming events in the near future. Please stay tuned.
Source: Innomd.org